Point - Proteomic patterns in biological fluids: Do they represent the future of cancer diagnostics?

被引：239

作者：

Diamandis, EP

机构：

[1] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada

[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada

来源：

CLINICAL CHEMISTRY | 2003年 / 49卷 / 08期

关键词：

D O I：

10.1373/49.8.1272

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：1272 / 1275

页数：4

共 19 条

[1]

Adam BL, 2002, CANCER RES, V62, P3609

[2]

Bedzyk WD, 1998, BIOTECHNOL APPL BIOC, V27, P249

[3] Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease - A prospective multicenter clinical trial [J].

Catalona, WJ ;

Partin, AW ;

Slawin, KM ;

Brawer, MK ;

Flanigan, RC ;

Patel, A ;

Richie, JP ;

deKernion, JB ;

Walsh, PC ;

Scardino, PT ;

Lange, PH ;

Subong, ENP ;

Parson, RE ;

Gasior, GH ;

Loveland, KG ;

Southwick, PC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (19) :1542-1547

[4] The ProteinChip ® Biomarker System from Ciphergen Biosystems:: a novel proteomics platform for rapid biomarker discovery and validation [J].

Chapman, K .

BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :82-87

[5] Re: Serum proteomic patterns for detection of prostate cancer [J].

Diamandis, EP .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (06) :489-490

[6]

Diamandis EP, 2002, CLIN CHEM, V48, P1145

[7] Proteomic patterns in serum and identification of ovarian cancer [J].

Diamandis, EP .

LANCET, 2002, 360 (9327) :170-170

[8]

Diamandis EP, 2002, TUMOR MARKERS PHYSL, P3

[9] The SELDI-TOF MS approach to proteomics: Protein profiling and biomarker identification [J].

Issaq, HJ ;

Veenstra, TD ;

Conrads, TP ;

Felschow, D .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 292 (03) :587-592

[10]

Li JN, 2002, CLIN CHEM, V48, P1296

← 1 2 →